With 21 September designated as World Alzheimer’s Day, a disease which constitutes the most common form of dementia, the Cyprus Institute of Neurology and Genetics (CING) announces the commencement of the clinical phase of the COMFORTage study against dementia.
Within the framework of the study, which aims to develop methods for the early prediction and prevention of dementia, healthy individuals as well as individuals with memory disorders over the age of 50 may register to participate. Drawing on the Institute’s multidimensional clinical expertise, participants will be assessed by a neurologist, neuropsychologist, speech and language therapist, physiotherapist and neurophysiologist. The results of these assessments will be compared with those of participants across Europe.
It is noteworthy that seven other countries are simultaneously conducting similar clinical studies with the aim of collecting harmonised data. These data concern the clinical and molecular profiles of participants, including biochemical and molecular biomarkers, which will be identified through specialised bioinformatics methods.
The findings are expected to lead to the development of healthcare models that will enable health professionals to provide dementia-related recommendations guided by advanced research and tailored to the individual profile of each patient.
The COMFORTage project is funded by the European Union and brings together health scientists, social scientists and researchers working across 39 organisations in 12 countries. Among these is CING, which is leading one category of clinical studies.
As part of the COMFORTage activities, CING, in collaboration with the Municipality of Nicosia, co-organised a public awareness event on dementia. Furthermore, smaller interactive workshops were held at the Institute’s premises with the aim of enhancing understanding and gathering recommendations from groups involved in dementia-related activity, such as dementia researchers, medical students and carers of people with dementia.
CING is committed to continuing such initiatives in order to raise public awareness about dementia and to incorporate perspectives from a wide range of disciplines. These activities will be announced via CING’s social media channels.
For further information about the study, or to register your interest in participating, you may contact us on 22392847 or via email at comfortage@cing.ac.cy. You may also visit the consortium’s website at https://comfortage.eu/.
Source: The Cyprus Institute of Neurology & Genetics | News & Events | Media (https://tinyurl.com/mr6sz7e4)